Clinical Trial Update: Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating intravitreal ranibizumab as a preoperative adjunct before vitrectomy for proliferative diabetic retinopathy, comparin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (Lucentis) (ranibizumab)

Snippet

Sponsor: Attila Vajas | Conditions: Diabetic Retinopathy | Phase 2 | Status: UNKNOWN